Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice.
Liyang DongYing WangTingting ZhengYanan PuYongbin MaXin QiWenzhe ZhangFei XueZirui ShanJiameng LiuXuefeng WangChaoming MaoPublished in: Stem cell research & therapy (2021)
Our findings provided the first evidence that hypoxic hUCMSC-derived EVs attenuated allergic airway inflammation and airway remodeling in chronic asthma mice, potentially creating new avenues for the treatment of asthma.